Diagnosis of ventilator-associated pneumonia [3]

New England Journal of Medicine

Volumn 356, Issue 14, 2007, Pages 1470-

  Marik, Paul E ^a   Baram, Michael ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; MEROPENEM; ANTIINFECTIVE AGENT;

ASPIRATION; BACTERIAL COLONIZATION; ENDOTRACHEAL TUBE; HUMAN; INTERMETHOD COMPARISON; LETTER; LUNG LAVAGE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PATHOGENESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; VENTILATOR ASSOCIATED PNEUMONIA; ISOLATION AND PURIFICATION; MICROBIOLOGY; NOTE; PENICILLIN RESISTANCE; PSEUDOMONAS; STAPHYLOCOCCUS AUREUS; TRACHEA;

ANTI-BACTERIAL AGENTS; BRONCHOALVEOLAR LAVAGE; HUMANS; METHICILLIN RESISTANCE; PNEUMONIA, VENTILATOR-ASSOCIATED; PSEUDOMONAS; STAPHYLOCOCCUS AUREUS; TRACHEA;

EID: 34047247003     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
2. Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000;31:Suppl 4:S131-S138.
3. Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998;157:531-9.